[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

Samenvatting: Protembis kondigt inschrijving van eerste patiënt in de PROTEMBO IDE-studie aan

[#item_full_content]NEW YORK & AACHEN, Duitsland–(BUSINESS WIRE)–Protembis GmbH (Protembis), een opkomend privébedrijf actief in cardiovasculaire medische hulpmiddelen,…

Swiss banking giant UBS to launch share buyback of up to $2 billion

[#item_full_content]UBS on Tuesday announced a new share repurchase program of up to $2 billion, with up…

Resumen: Protembis anuncia la inscripción del primer paciente en el ensayo fundamental de EDI PROTEMBO

[#item_full_content]NUEVA YORK & AACHEN, Alemania–(BUSINESS WIRE)–Protembis GmbH (Protembis), una empresa privada emergente de dispositivos médicos cardiovasculares,…

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]